The discovery of coregulators and other recent advances in our understanding of the molecular biology of nuclear receptor action ... of SERMs and other selective NR modulators, and we anticipate ...

As a next-generation selective estrogen receptor modulator (SERM), (Z)-endoxifen has demonstrated superior potency, broad anti-tumor activity, and a favorable safety profile across multiple breast ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a ...

Ospemifene, an oral selective estrogen receptor modulator, is a nonestrogen option for the treatment of moderate-to-severe dyspareunia due to menopause. The REVIVE survey assessed women's ...

(Z)-endoxifen is one of the most potent Selective Estrogen Receptor Modulator (SERM) for estrogen receptor inhibition and may cause estrogen receptor degradation. It has also been shown to have ...